Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company Cash on Hand 2007–2025
Bristol-Myers Squibb Company annual cash on hand history from 2008 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Bristol-Myers Squibb Company cash on hand as of December 31, 2025: 10.21B, a 1.32% decrease year-over-year.
- Bristol-Myers Squibb Company cash on hand for 2025 were 10.21B, a 1.32% decrease from 2024.
- Bristol-Myers Squibb Company cash on hand for 2024 were 10.35B, a 9.75% decrease from 2023.
- Bristol-Myers Squibb Company cash on hand for 2023 were 11.46B, a 25.66% increase from 2022.
- Bristol-Myers Squibb Company cash on hand for 2022 were 9.12B.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bristol-Myers Squibb Company Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $10,209 |
| 2024 | $10,346 |
| 2023 | $11,464 |
| 2022 | $9,123 |
| 2021 | $13,979 |
| 2020 | $14,546 |
| 2019 | $12,346 |
| 2018 | $6,911 |
| 2017 | $5,421 |
| 2016 | $4,237 |
| 2015 | $2,385 |
| 2014 | $5,571 |
| 2013 | $3,586 |
| 2012 | $1,656 |
| 2011 | $5,776 |
Bristol-Myers Squibb Company Cash on Hand — FAQ
Bristol-Myers Squibb Company (BMY) cash on hand over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMY's cash on hand history?
The chart and table above show Bristol-Myers Squibb Company's cash on hand by year and by quarter, including the growth rate.